Growth and nutritional status of children with homozygous sickle cell disease

Annals of Tropical Paediatrics

Volumn 28, Issue 3, 2008, Pages 165-189

  Al Saqladi, A W M ^a,b   Cipolotti, R ^d   Fijnvandraat, K ^e   Brabin, B J ^b,c,e  

^a Aden University   (Yemen)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^d FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYANOCOBALAMIN; FOLIC ACID; HYDROXYUREA; OMEGA 3 FATTY ACID; PYRIDOXINE; PYROGLUTAMATE MAGNESIUM; TRACE ELEMENT; ZINC;

AFRICA; ANTHROPOMETRY; BLOOD TRANSFUSION; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CENTRAL AMERICA; CHILD; CHILD GROWTH; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOCRINE DISEASE; ENERGY METABOLISM; EUROPE; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; GROWTH DISORDER; GROWTH RETARDATION; HOMOZYGOTE; HUMAN; LONGITUDINAL STUDY; MALNUTRITION; MEDICAL LITERATURE; MEDLINE; METABOLIC DISORDER; NORTH AMERICA; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; REVIEW; SAMPLE SIZE; SAUDI ARABIA; SICKLE CELL ANEMIA; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTHROPOMETRY; BODY COMPOSITION; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH; GROWTH DISORDERS; HOMOZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NUTRITIONAL STATUS; SEVERITY OF ILLNESS INDEX;

EID: 54349103017     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/146532808X335624     Document Type: Review

References (169)

1. Serjeant GR. Sickle Cell Disease, 2nd edn. Oxford: Oxford University Press, 1992.
2. Enwonwu CO. Nutritional support in sickle cell anaemia: Theoretical considerations. J Natl Med Assoc 1988; 80:139-44.
3. Wethers DL. Delayed growth and sexual maturation in sickle cell disease. Ann N Y Acad Sci 1989; 565:137-42.
4. Warrier RP, Kuvibidila S, Gordon L, Humbert J. Transport proteins and acute phase reactant proteins in children with sickle cell anaemia. J Natl Med Assoc 1994; 86:33-9.
5. Henderson RA, Saavedra JM, Dover GJ. Prevalence of impaired growth in children with homozygous sickle cell anaemia. Am J Med Sci 1994; 307:405-7.
6. Konotey-Ahulu F. The sickle cell disease patient: Natural history from a clinico-epidemiological study of the first 1550 patients of Korle Bu Hospital Sickle Cell Clinic. Watford, UK: Tetteh-A'Domeno, 1996.
7. Serjeant GR. The clinical features of sickle cell disease. Baillières Clin Haematol 1993; 6:93-115.
8. Scott RB, Ferguson AD, Jenkins ME, Clark HM. Studies in sickle-cell anaemia. VIII. Further observations on the clinical manifestations of sickle-cell anaemia in children. Am J Dis Child 1955; 90:682-91.
9. Malinauskas BM, Gropper SS, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Impact of acute illness on nutritional status of infants and young children with sickle cell disease. J Am Diet Assoc 2000; 100:330-4.
10. Fung EB, Malinauskas BM, Kawchak DA, et al. Energy expenditure and intake in children with sickle cell disease during acute illness. Clin Nutr 2001; 20:131-8.
11. Lowry MF, Desai P, Ashcroft MT, Serjeant BF, Serjeant GR. Heights and weights of Jamaican children with homozygous sickle cell disease. Hum Biol 1977; 49:429-36.
12. Singhal A, Morris J, Thomas P, Dover G, Higgs D, Serjeant G. Factors affecting prepubertal growth in homozygous sickle cell disease. Arch Dis Child 1996; 74:502-6.
13. Singhal A, Doherty JF, Raynes JG, et al. Is there an acute-phase response in steady-state sickle cell disease? Lancet 1993; 341:651-3.
14. Hibbert JM, Hsu LL, Bhathena SJ, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood) 2005; 230:68-74.
15. Heyman MB, Vichinsky E, Katz R, et al. Growth retardation in sickle-cell disease treated by nutritional support. Lancet 1985; 1:903-6.
16. Wang WC, Morales KH, Scher CD, et al. Effect of long-term transfusion on growth in children with sickle cell anaemia: Results of the STOP trial. J Pediatr 2005; 147:244-7.
17. Badaloo A, Emond A, Venugopal S, Serjeant G, Jackson AA. The effect of splenectomy on whole body protein turnover in homozygous sickle cell disease. Acta Paediatr Scand 1991; 80:103-5.
18. Singhal A, Thomas P, Kearney T, Venugopal S, Serjeant G. Acceleration in linear growth after splenectomy for hypersplenism in homozygous sickle cell disease. Arch Dis Child 1995; 72:227-9.
19. Fung EB, Barden EM, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease. J Pediatr Hematol Oncol 2001; 23:604-8.
20. Hankins JS, Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anaemia: The HUSOFT extension study. Blood 2005; 106:2269-75.
21. Winsor T, Burch G. Habitus of patients with active sickle cell anaemia of long duration. Arch Intern Med 1945; 76:47-53.
22. Whitten CF. Growth status of children with sickle-cell anaemia. Am J Dis Child 1961; 102:355-64.
23. Jimenez CT, Scott RB, Henry LW, Sampson CC, Ferguson AD. Studies in sickle cell anaemia. XXVI. The effects of homozygous sickle cell disease on the onset of menarche, pregnancy, fertility, pubescent changes, and body growth in Negro subjects. Am J Dis Child 1966; 111:497-504.
24. McCormack MK, Dicker L, Katz SH, et al. Growth patterns of children with sickle-cell disease. Hum Biol 1976; 48:429-37.
25. Booker CR, Scott RB, Ferguson AD. Studies in sickle cell anaemia. Xxii. Clinical manifestations of sickle cell anaemia during the first two years of life. Clin Pediatr (Phila) 1964; 3:111-15.
26. Kramer MS, Rooks Y, Washington LA, Pearson HA. Pre- and postnatal growth and development in sickle cell anaemia. J Pediatr 1980; 96:857-60.
27. Luban NL, Leikin SL, August GA. Growth and development in sickle cell anaemia. Preliminary report. Am J Pediatr Hematol Oncol 1982; 4:61-5.
28. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med 1984; 311:7-12.
29. Phebus CK, Gloninger MF, Maciak BJ. Growth patterns by age and sex in children with sickle cell disease. J Pediatr 1984; 105:28-33.
30. Cepeda ML, Allen FH, Cepeda NJ, Yang YM. Physical growth, sexual maturation, body image and sickle cell disease. J Natl Med Assoc 2000; 92:10-14.
31. Zemel BS, Kawchak DA, Ohene-Frempong K, Schall JI, Stallings VA. Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res 2007; 61:607-13.
32. Stevens MC, Maude GH, Cupidore L, Jackson H, Hayes RJ, Serjeant GR. Prepubertal growth and skeletal maturation in children with sickle cell disease. Pediatrics 1986; 78:124-32.
33. Silva CM, Viana MB. Growth deficits in children with sickle cell disease. Arch Med Res 2002; 33:308-12.
34. Modebe O, Ifenu SA. Growth retardation in homozygous sickle cell disease: Role of calorie intake and possible gender-related differences. Am J Hematol 1993; 44:149-54.
35. Ashcroft MT, Serjeant GR, Desai P. Heights, weights, and skeletal age of Jamaican adolescents with sickle cell anaemia. Arch Dis Child 1972; 47:519-24.
36. Ashcroft MT, Serjeant GR. Growth, morbidity, and mortality in a cohort of Jamaican adolescents with homozygous sickle cell disease. West Indian Med J 1981; 30:197-201.
37. Stevens MC, Hayes RJ, Serjeant GR. Body shape in young children with homozygous sickle cell disease. Pediatrics 1983; 71:610-14.
38. Singhal A, Thomas P, Cook R, Wierenga K, Serjeant G. Delayed adolescent growth in homozygous sickle cell disease. Arch Dis Child 1994; 71:404-8.
39. Thomas PW, Singhal A, Hemmings-Kelly M, Serjeant GR. Height and weight reference curves for homozygous sickle cell disease. Arch Dis Child 2000; 82:204-8.
40. Souza NM, Tone LG, Collares EF, Souza IM. Valores séricos de zinco em crianças com hemoglobinopatia (anaemia falciforme, beta talassemia e S-talassemia/serum zinc levels in children with homoglobinopathy (sickle cell anaemia, beta-talassemia and S-talassemia). J Pediatr (Rio J) 1983; 55:385-8.
41. Figuera L, Carneiro L, Villarroel J. Anaemia drepanocítica y niveles sericos de zinc/Drepanocitic anaemia and zinc seric tenels. Arch Venez Pueric Pediatr 1994; 57:182-5.
42. Britto MMS, Alves AFP, Rabelo MM. Alterações no desenvolvimento somático e sexual na anaemia falciforme (SS) e traço falcêmico (AS) [Changes of the somatic and sexual development in sickle cell anaemia (SS) and sickling trace (AS)]. Arq Bras Endocrinol Metab 1985; 29:111-14.
43. Zago MA, Kerbauy J, Souza HM, et al. Growth and sexual maturation of Brazilian patients with sickle cell diseases. Trop Geogr Med 1992; 44:317-21.
44. Pellegrini-Braga J, Kerbauy J, Fisberg M. Zinc, copper and iron and their interrelations in the growth of sickle cell patients (Zinc, cobre, hierro y su interrelación con el crescimiento de niños con anaemia falciforme). Arch Latinoam Nutr 1995; 45:198-203.
45. Cipolotti R, Caskey MF, Franco RP, et al. Childhood and adolescent growth of patients with sickle cell disease in Aracaju, Sergipe, north-east Brazil. Ann Trop Paediatr 2000; 20:109-13.
46. Gonzáles-Fernándes P, Svarch E, Garriga E. Crecimiento y desarrollo en las hemoglobinopatias S (Growth and development in hemoglobinopathy-S). Rev Cuba Hematol Inmunol Hemoter 1992; 8:12-22.
47. Ebomoyi E, Adedoyin MA, Ogunlesi FO. A comparative study of the growth status of children with and without SS disease at Ilorin, Kwara State, Nigeria. Afr J Med Med Sci 1989; 18:69-74.
48. Oyedeji GA. The health, growth and educational performance of sickle cell disease children. East Afr Med J 1991; 68:181-9.
49. Oredugba FA, Savage KO. Anthropometric finding in Nigerian children with sickle cell disease. Pediatr Dent 2002; 24:321-5.
50. Mabiala-Babela JR, Massamba A, Tsiba JB, Moulongo JG, Nzingoula S, Senga P. Body composition in Negro African children suffering from sickle cell disease. A mixed cross-sectional longitudinal study in Brazzaville, Congo. Bull Soc Pathol Exot 2005; 98:394-9.
51. M'Pemba-Loufoua AB, Nzingoula S, Moubouh-Akouala F, Oba A. Pubertal development in girls with homozygote sickle cell disease. A propos of 72 cases. Bull Soc Pathol Exot 2001; 94:326-9.
52. Thuilliez V, Ditsambou V, Mba JR, Mba Meyo S, Kitengue J. Current aspects of sickle cell disease in children in Gabon. Arch Pediatr 1996; 3:668-74.
53. Athale UH, Chintu C. The effect of sickle cell anaemia on adolescents and their growth and development - lessons from the sickle cell anaemia clinic. J Trop Pediatr 1994; 40:246-52.
54. Soliman AT, el Zalabany M, Amer M, Ansari BM. Growth and pubertal development in transfusion-dependent children and adolescents with thalassemia major and sickle cell disease: A comparative study. J Trop Pediatr 1999; 45:23-30.
55. Mansour AA. Influence of sickle hemoglobinopathy on growth and development of young adult males in Southern Iraq. Saudi Med J 2003; 24:544-6.
56. Jaiyesimi F, Pandey R, Bux D, Sreekrishna Y, Zaki F, Krishnamoorthy N. Sickle cell morbidity profile in Omani children. Ann Trop Paediatr 2002; 22:45-52.
57. Perrine RP, John P, Pembrey M, Perrine S. Sickle cell disease in Saudi Arabs in early childhood. Arch Dis Child 1981; 56:187-92.
58. Mukherjee MB, Gangakhedkar RR. Physical growth of children with sickle cell disease. Indian J Hum Genet 2004; 10:70-2.
59. Caruso-Nicoletti M, Mancuso M, Spadaro G, Samperi P, Consalvo C, Schiliro G. Growth and development in white patients with sickle cell diseases. Am J Pediatr Hematol Oncol 1992; 14:285-8.
60. Mann JR. Sickle cell haemoglobinopathies in England. Arch Dis Child 1981; 56:676-83.
61. Patey RA, Sylvester KP, Rafferty GF, Dick M, Greenough A. The importance of using ethnically appropriate reference ranges for growth assessment in sickle cell disease. Arch Dis Child 2002; 87:352-3.
62. Barden EM, Kawchak DA, Ohene-Frempong K, Stallings VA, Zemel BS. Body composition in children with sickle cell disease. Am J Clin Nutr 2002; 76:218-25.
63. Badaloo A, Jackson AA, Jahoor F. Whole body protein turnover and resting metabolic rate in homozygous sickle cell disease. Clin Sci (Lond) 1989; 77:93-7.
64. Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR. Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr 1993; 57:32-4.
65. Kopp-Hoolihan LE, van Loan MD, Mentzer WC, Heyman MB. Elevated resting energy expenditure in adolescents with sickle cell anaemia. J Am Diet Assoc 1999; 99:195-9.
66. Borel MJ, Buchowski MS, Turner EA, Peeler BB, Goldstein RE, Flakoll PJ. Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease. Am J Physiol 1998; 274:e357-64.
67. Borel MJ, Buchowski MS, Turner EA, Goldstein RE, Flakoll PJ. Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease. Am J Clin Nutr 1998; 68:607-14.
68. Singhal A, Davies P, Wierenga KJ, Thomas P, Serjeant G. Is there an energy deficiency in homozygous sickle cell disease? Am J Clin Nutr 1997; 66:386-90.
69. Barden EM, Zemel BS, Kawchak DA, Goran MI, Ohene-Frempong K, Stallings VA. Total and resting energy expenditure in children with sickle cell disease. J Pediatr 2000; 136:73-9.
70. Jain SK, Ross JD, Duett J, Herbst JJ. Low plasma prealbumin and carotenoid levels in sickle cell disease patients. Am J Med Sci 1990; 299:13-15.
71. Van der Jagt DJ, Kanellis GJ, Isichei C, Patuszyn A, Glew RH. Serum and urinary amino acid levels in sickle cell disease. J Trop Pediatr 1997; 43:220-5.
72. Enomoto TM, Isichei C, Van der Jagt DJ, Fry DE, Glew RH. Decreased polyunsaturated fatty acids in sickle cell anaemia. J Trop Pediatr 1998; 44:28-34.
73. el-Hazmi MA, Warsy AS, Al-Swailem A, Al-Swailem A, Bahakim H. Red cell genetic disorders and plasma lipids. J Trop Pediatr 1995; 41:202-5.
74. Van der Jagt DJ, Shores J, Okorodudu A, Okolo SN, Glew RH. Hypocholesterolemia in Nigerian children with sickle cell disease. J Trop Pediatr 2002; 48:156-61.
75. Ren H, Obike I, Okpala I, Ghebremeskel K, Ugochukwu C, Crawford M. Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2005; 72:415-21.
76. Buchowski MS, de la Fuente FA, Flakoll PJ, Chen KY, Turner EA. Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anaemia. Am J Physiol Endocrinol Metab 2001; 280:e518-27.
77. Lal A, Fung EB, Pakbaz Z, Hackney-Stephens E, Vichinsky EP. Bone mineral density in children with sickle cell anaemia. Pediatr Blood Cancer 2006; 47:901-6.
78. Salman EK, Haymond MW, Bayne E, et al. Protein and energy metabolism in prepubertal children with sickle cell anaemia. Pediatr Res 1996; 40:34-40.
79. Williams R, Olivi S, Li CS, et al. Oral glutamine supplementation decreases resting energy expenditure in children and adolescents with sickle cell anaemia. J Pediatr Hematol Oncol 2004; 26:619-25.
80. Olambiwonnu NO, Penny R, Frasier SD. Sexual maturation in subjects with sickle cell anaemia: Studies of serum gonadotropin concentration, height, weight, and skeletal age. J Pediatr 1975; 87:459-64.
81. Abbasi AA, Prasad AS, Ortega J, Congco E, Oberleas D. Gonadal function abnormalities in sickle cell anaemia. Studies in adult male patients. Ann Intern Med 1976; 85:601-5.
82. Parshad O, Stevens MC, Preece MA, Thomas PW, Serjeant GR. The mechanism of low testosterone levels in homozygous sickle-cell disease. West Indian Med J 1994; 43:12-14.
83. Singhal A, Gabay L, Serjeant GR. Testosterone deficiency and extreme retardation of puberty in homozygous sickle-cell disease. West Indian Med J 1995; 44:20-3.
84. Landefeld CS, Schambelan M, Kaplan SL, Embury SH. Clomiphene-responsive hypogonadism in sickle cell anaemia. Ann Intern Med 1983; 99:480-3.
85. Dada OA, Nduka EU. Endocrine function and haemoglobinopathies: Relation between the sickle cell gene and circulating plasma levels of testosterone, luteinising hormone (LH) and follicle stimulating hormone (FSH) in adult males. Clin Chim Acta 1980; 105:269-73.
86. Serjeant GR, Singhal A, Hambleton IR. Sickle cell disease and age at menarche in Jamaican girls: Observations from a cohort study. Arch Dis Child 2001; 85:375-8.
87. El-Hazmi MA, Bahakim HM, Al-Fawaz I. Endocrine functions in sickle cell anaemia patients. J Trop Pediatr 1991; 38:307-13.
88. Lukanmbi FA, Adeyokunnu AA, Osifo BO, Bolodeoku JO, Dada OA. Endocrine function and haemoglobinopathies: Biochemical assessment of thyroid function in children with sickle-cell disease. Afr J Med Med Sci 1986; 15:25-8.
89. Soliman AT, Darwish A, Asfour MG. Empty sella in short children with and without hypothalamic-pituitary abnormalities. Indian J Pediatr 1995; 62:597-603.
90. Soliman AT, Darwish A, Mohammed SH, Bassiony MR, El-Banna N, Asfour M. Circulating growth hormone (GH), insulin-like growth factor-I (IGF-I) and free thyroxine, GH response to clonidine provocation and CT scanning of the hypothalamic-pituitary area in children with sickle cell disease. J Trop Pediatr 1995; 41:285-9.
91. Soliman AT, El-Banna N, Al-Salmi I, De Silva V, Craig A, Asfour M. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease. Metabolism 1997; 46:1241-5.
92. Soliman AT, Bererhi H, Darwish A, Al-Zalabani MM, Wali Y, Ansari B. Decreased bone mineral density in prepubertal children with sickle cell disease: Correlation with growth parameters, degree of siderosis and secretion of growth factors. J Trop Pediatr 1998; 44:194-8.
93. Luporini SM, Bendit I, Manhani R, Bracco OL, Manzella L, Giannella-Neto D. Growth hormone and insulin-like growth factor I axis and growth of children with different sickle cell anaemia haplotypes. J Pediatr Hematol Oncol 2001; 23:357-63.
94. Collett-Solberg PF, Fleenor D, Schultz WH,Ware RE. Short stature in children with sickle cell anaemia correlates with alterations in the IGF-I axis. J Pediatr Endocrinol Metab 2007; 20:211-18.
95. Nunlee-Bland G, Rana SR, Houston-Yu PE, Odonkor W. Growth hormone deficiency in patients with sickle cell disease and growth failure. J Pediatr Endocrinol Metab 2004; 17:601-6.
96. Finan AC, Elmer MA, Sasanow SR, McKinney S, Russell MO, Gill FM. Nutritional factors and growth in children with sickle cell disease. Am J Dis Child 1988; 142:237-40.
97. Gray NT, Bartlett JM, Kolasa KM, Marcuard SP, Holbrook CT, Horner RD. Nutritional status and dietary intake of children with sickle cell anaemia. Am J Pediatr Hematol Oncol 1992; 14:57-61.
98. Williams R, George EO, Wang W. Nutrition assessment in children with sickle cell disease. J Assoc Acad Minor Phys 1997; 8:44-8.
99. Kawchak DA, Schall JI, Zemel BS, Ohene-Frempong K, Stallings VA. Adequacy of dietary intake declines with age in children with sickle cell disease. J Am Diet Assoc 2007; 107:843-8.
100. Jonsson U, Roath OS, Kirkpatrick CI. Nutritional megaloblastic anaemia associated with sickle cell states. Blood 1959; 14:535-47.
101. MacIver JE, Went LN. Sickle-cell anaemia complicated by megaloblastic anaemia of infancy. Br Med J 1960; 1:775-9.
102. Alperin JB. Folic acid deficiency complicating sickle cell anaemia. A study on the response to titrated doses of folic acid. Arch Intern Med 1967; 120:298-306.
103. Lopez R, Shimizu N, Cooperman JM. Recurrent folic acid deficiency in sickle cell disease. Am J Dis Child 1973; 125:544-8.
104. Watson-Williams EJ. Folic acid deficiency in sickle-cell anaemia. East Afr Med J 1962; 39:213-21.
105. Pearson HA, Cobb WT. Folic acid studies in sickle-cell anaemia. J Lab Clin Med 1964; 64:913-21.
106. Liu YK. Folate deficiency in children with sickle cell anaemia. Am J Dis Child 1974; 127:389-93.
107. Rabb LM, Grandison Y, Mason K, Hayes RJ, Serjeant B, Serjeant GR. A trial of folate supplementation in children with homozygous sickle cell disease. Br J Haematol 1983; 54:589-94.
108. Serjeant GR. Treatment of sickle cell disease in early childhood in Jamaica. Am J Pediatr Hematol Oncol 1985; 7:235-9.
109. Wang WC. Role of nutritional supplement in sickle cell disease. J Pediatr Hematol Oncol 1999; 21:176-8.
110. 6 deficiency in sickle cell anaemia. Am J Clin Nutr 1984; 40:235-9.
111. 6 status of children with sickle cell disease. J Pediatr Hematol Oncol 2002; 24:463-9.
112. 12 levels in patients with severe sickle cell disease. J Intern Med 1995; 237:551-5.
113. Ajayi OA, George BO, Ipadeola T. Clinical trial of riboflavin in sickle cell disease. East Afr Med J 1993; 70:418-21.
114. Clarke R. Homocysteine-lowering trials for prevention of heart disease and stroke. Semin Vasc Med 2005; 5:215-22.
115. Lowenthal EA, Mayo MS, Cornwell PE, Thornley-Brown D. Homocysteine elevation in sickle cell disease. J Am Coll Nutr 2000; 19:608-12.
116. Balasa VV, Kalinyak KA, Bean JA, Stroop D, Gruppo RA. Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease. J Pediatr Hematol Oncol 2002; 24:374-9.
117. Marian TK. Folic Acid and Homocysteine Levels in Children with Sickle Cell Disease in The Gambia. Liverpool School of Tropical Medicine, UK: Master of Tropical Paediatrics thesis, 2001.
118. Houston PE, Rana S, Sekhsaria S, Perlin E, Kim KS, Castro OL. Homocysteine in sickle cell disease: Relationship to stroke. Am J Med 1997; 103:192-6.
119. Ballas SK, Saidi P. Thrombosis, megaloblastic anaemia, and sickle cell disease: A unified hypothesis. Br J Haematol 1997; 96:879-80.
120. van der Dijs FP, Fokkema MR, Dijck-Brouwer DA, et al. Optimization of folic acid, vitamin B(12), and vitamin B(6) supplements in pediatric patients with sickle cell disease. Am J Hematol 2002; 69:239-46.
121. 12 Supplmentation. Liverpool School of Tropical Medicine, UK: Master of Tropical Paediatrics thesis, 2002.
122. Schall JI, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. Vitamin A status, hospitalizations, and other outcomes in young children with sickle cell disease. J Pediatr 2004; 145:99-106.
123. Prasad AS, Schoomaker EB, Ortega J. Zinc deficiency in sickle cell disease. Clin Chem 1975; 21:582-7.
124. Prasad AS, Ortega J, Brewer GJ, Oberleas D, Schoomaker EB. Trace elements in sickle cell disease. JAMA 1976; 235:2396-8.
125. Leonard MB, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. Plasma zinc status, growth, and maturation in children with sickle cell disease. J Pediatr 1998; 132:467-71.
126. Zemel BS, Kawchak DA, Fung EB, Ohene-Frempong K, Stallings VA. Effect of zinc supplementation on growth and body composition in children with sickle cell disease. Am J Clin Nutr 2002; 75:300-7.
127. Erlandson ME, Schulman I, Smith CH. Studies on congenital hemolytic syndromes. III. Rates of destruction and production of erythrocytes in sickle cell anaemia. Pediatrics 1960; 25:629-44.
128. O'Brien RT. Iron burden in sickle cell anaemia. J Pediatr 1978; 92:579-82.
129. Davies S, Henthorn J, Brozovic M. Iron deficiency in sickle cell anaemia. J Clin Pathol 1983; 36:1012-15.
130. Jeyakumar LH, Akpanyung EO, Akinyemi AA, Emerole GO. An investigation into the iron status of children with sickle-cell disease in western Nigeria. J Trop Pediatr 1987; 33:326-8.
131. Nagaraj Rao J, Sur AM. Iron deficiency in sickle cell disease. Acta Paediatr Scand 1980; 69:337-40.
132. Okeahialam TC, Obi GO. Iron deficiency in sickle cell anaemia in Nigerian children. Ann Trop Paediatr 1982; 2:89-92.
133. Oluboyede OA, Ajayi OA, Adeyokunnu AA. Iron studies in patients with sickle cell disease. Afr J Med Med Sci 1981; 10:1-7.
134. Vichinsky E, Kleman K, Embury S, Lubin B. The diagnosis of iron deficiency anaemia in sickle cell disease. Blood 1981; 58:963-8.
135. Stettler N, Zemel BS, Kawchak DA, Ohene-Frempong K, Stallings VA. Iron status of children with sickle cell disease. J Parenter Enteral Nutr 2001; 25:36-8.
136. Serjeant GR, Grandison Y, Mason K, Serjeant B, Sewell A, Vaidya S. Haematological indices in normal negro children: A Jamaican cohort from birth to five years. Clin Lab Haematol 1980; 2:169-78.
137. King L, Reid M, Forrester TE. Iron deficiency anaemia in Jamaican children, aged 1-5 years, with sickle cell disease. West Indian Med J 2005; 54:292-6.
138. Washington R, Boggs DR. Urinary iron in patients with sickle cell anaemia. J Lab Clin Med 1975; 86:17-23.
139. Lincoln TL, Aroesty J, Morrison P. Iron-deficiency anaemia and sickle-cell disease: Hypothesis. Lancet 1973; 2:260-1.
140. Castro O, Poillon WN, Finke H, Massac E. Improvement of sickle cell anaemia by iron-limited erythropoiesis. Am J Hematol 1994; 47:74-81.
141. Bouchair N, Manigne P, Kanfer A, et al. Prevention of sickle cell crises with multiple phlebotomies. Arch Pediatr 2000; 7:249-55.
142. Haddy TB, Castro O. Overt iron deficiency in sickle cell disease. Arch Intern Med 1982; 142:1621-4.
143. Koduri PR. Iron in sickle cell disease: A review why less is better. Am J Hematol 2003; 73:59-63.
144. Oski FA. Iron deficiency in infancy and childhood. N Engl J Med 1993; 329:190-3.
145. Sindel LJ, Baliga BS, Bendich A, Mankad V. Nutritional deficiencies associated with vitamin E deficiency in sickle cell patients; the effect of vitamin supplementation. Nutr Res 1990; 10:267-73.
146. Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in children with sickle cell anaemia. East Afr Med J 1990; 67:720-5.
147. Shukla P, Graham SM, Borgstein A, Nhlane A, Harper G, Brabin BJ. Sickle cell disease and vitamin E deficiency in children in developing countries. Trans R Soc Trop Med Hyg 2000; 94:109.
148. Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled erythrocytes in sickle cell anaemia patients given vitamin E. Am J Clin Nutr 1980; 33:968-71.
149. Westerman MP, Zhang Y, McConnell JP, et al. Ascorbate levels in red blood cells and urine in patients with sickle cell anaemia. Am J Hematol 2000; 65:174-5.
150. Buison AM, Kawchak DA, Schall J, Ohene-Frempong K, Stallings VA, Zemel BS. Low vitamin D status in children with sickle cell disease. J Pediatr 2004; 145:622-7.
151. Zehtabchi S, Sinert R, Rinnert S, et al. Serum ionized magnesium levels and ionized calcium-to-magnesium ratios in adult patients with sickle cell anaemia. Am J Hematol 2004; 77:215-22.
152. Natta CL, Chen LC, Chow CK. Selenium and glutathione peroxidase levels in sickle cell anaemia. Acta Haematol 1990; 83:130-2.
153. Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anaemia: A potential nutritional approach for a molecular disease. Nutrition 2000; 16:330-8.
154. Takasu J, Uykimpang R, Sunga MA, Amagase H, Niihara Y. Aged garlic extract is a potential therapy for sickle-cell anaemia. J Nutr 2006; 136:803-5S.
155. Tomer A, Kasey S, Connor WE, Clark S, Harker LA, Eckman JR. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost 2001; 85:966-74.
156. Okpala IE. New therapies for sickle cell disease. Hematol Oncol Clin North Am 2005; 19:975-87, ix.
157. Morris CR, Morris SM Jr, Hagar W, et al. Arginine therapy: A new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med 2003; 168:63-9.
158. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004; 364:1343-60.
159. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium pidolate: Effects of long-term administration in patients with sickle cell disease. Br J Haematol 2000; 108:284-9.
160. Prasad AS. Malnutrition in sickle cell disease patients. Am J Clin Nutr 1997; 66:423-4.
161. Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell disease. Am J Hematol 1987; 24:441-55.
162. Rahimy MC, Gangbo A, Ahouignan G, et al. Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anaemia in a sub-Saharan African setting. Blood 2003; 102:834-8.
163. Mankad VN. Growth and development in sickle hemoglobinopathies. Am J Pediatr Hematol Oncol 1992; 14:283-4.
164. Knight S, Singhal A, Thomas P, Serjeant G. Factors associated with lowered intelligence in homozygous sickle cell disease. Arch Dis Child 1995; 73:316-20.
165. Zimmerman SA, Ware RE. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol 1998; 59:267-72.
166. Kutlar A, Kutlar F, Turker I, Tural C. The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease. Hemoglobin 2001; 25:213-17.
167. Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Am J Hematol 2004; 76:307-9.
168. Couto FD, Boas WV, Lyra I, et al. A C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism and G20210A mutation in the prothrombin gene of sickle cell anaemia patients from Northeast Brazil. Hemoglobin 2004; 28:237-41.
169. Nagel RL, Steinberg MH. Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anaemia. Pediatr Pathol Mol Med 2001; 20:123-36.